Compare RXRX & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXRX | PRVA |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | 2021 | 2021 |
| Metric | RXRX | PRVA |
|---|---|---|
| Price | $3.47 | $22.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | $7.50 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 21.9M | 740.6K |
| Earning Date | 02-27-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.88 |
| EPS | N/A | ★ 0.14 |
| Revenue | $43,689,000.00 | ★ $2,042,569,000.00 |
| Revenue This Year | $6.74 | $23.19 |
| Revenue Next Year | $34.31 | $13.51 |
| P/E Ratio | ★ N/A | $159.84 |
| Revenue Growth | N/A | ★ 19.01 |
| 52 Week Low | $3.45 | $18.77 |
| 52 Week High | $12.36 | $26.51 |
| Indicator | RXRX | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 33.33 | 46.74 |
| Support Level | $3.54 | $21.29 |
| Resistance Level | $4.09 | $22.16 |
| Average True Range (ATR) | 0.26 | 0.90 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 3.10 | 44.17 |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.